KALV — Kalvista Pharmaceuticals Inc

Stock analysis, AI verdict, fundamentals & technical signals

Rating: NEUTRAL

Price: $27.00 Analyst target: $27.00 Upside: 0.00%

See the full interactive analysis & chart →

Informational only — not investment advice.